奥沙利铂与紫杉醇分别联合5-Fu在胃癌根治术后的应用效果比较

Comparison of the clinical effects between oxaliplatin and paclitaxel respectively combined with 5-Fu on the treatment of gastric cancer after radical resection

目的比较奥沙利铂(L-OHP)及紫杉醇(PTX)分别联合5-氟尿嘧啶(5-Fu)化疗方案在胃癌根治术后的应用效果及安全性。方法选取2010-06~2013-05该院收治的66例胃癌根治术后患者作为研究对象,按入院顺序编号半随机分为A、B两组各33例。A组采用奥沙利铂联合5-Fu术后辅助化疗方案,B组采用紫杉醇联合5-Fu方案,均随访2年,统计肿瘤复发率、转移率、患者无瘤生存率、总生存率及毒副反应发生率。结果 A组、B组术后1年、2年肿瘤复发、转移率比较差异无统计学意义(P>0.05)。A、B组术后1年、2年无瘤生存率、总体生存率比较差异均无统计学意义(P>0.05)。A组Ⅲ~Ⅳ度中性粒细胞减少,恶心、呕吐,周围神经毒性、发热、肝功能异常发生率略高于B组,但差异无统计学意义(P>0.05)。结论奥沙利铂与紫杉醇分别联合5-Fu在胃癌根治术后辅助化疗中均有确切疗效,患者均可耐受,安全性较高。

Objective To compare the clinical effects and safety between oxaliplatin（L-OHP） and paclitaxel（PTX） respectively combined with 5-fluorouracil（5-Fu） chemotherapy on the patients with gastric cancer after radical resection. Methods Sixty-six patients who underwent radical resection of gastric cancer were selected as the study subjects. They were numbered in the order of admission,and were randomly divided into group A and group B,with33 cases in each group. The group A was treated with L-OHP combined with 5-Fu adjuvant chemotherapy,while the group B was treated with PTX combined 5-Fu. Both of the two groups were followed up for 2 years. The tumor recurrence rate,metastasis rate,tumor-free survival rate,overall survival rate and incidence of toxic and side effects were compared between the two groups. Results There were no significant differences in postoperative 1-year or 2-year tumor recurrence and metastasis rate between the group A and the group B（P〉0. 05）; There were no differences in postoperative 1-year or 2-year disease-free survival rates and overall survival rates between the group A and the group B（P〉0. 05）; The incidences of grade Ⅲ ～ Ⅳ neutropenia,nausea and vomiting,peripheral nerve toxicity,fever and abnormal liver function in the group A were slightly higher than those in the group B but there were no significant differences between the two groups（P〉0. 05）. Conclusion L-OHP and PTX respectively combined with 5-Fu in adjuvant chemotherapy are both safe and effective in the treatment of gastric cancer after radical resection.